Myriad Group AG

Equities

MYRN

CH0019624805

Software

Delayed Swiss Exchange 5-day change 1st Jan Change
- CHF -.--% Intraday chart for Myriad Group AG -27.92% -62.93%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Syncona’s Takeover of Freeline Therapeutics Becomes Effective MT
Syncona's Fiscal Q3 NAV Declines MT
Syncona to Take Over Freeline Therapeutics MT
Syncona Swings to Fiscal H1 Loss; Invest Income Falls MT
Earnings Flash (SYNC.L) SYNCONA Posts Fiscal H1 Loss GBX-8.01 MT
Syncona Submits Takeover Bid for Freeline Therapeutics MT
Syncona Launches Up to GBP40 Million Share Buyback Program MT
Syncona Flags GBP55 Million Valuation Impact as Novartis' Stops Eye Disease Drug Development MT
Myriad : Syncona's Gyroscope Therapeutics Says Interim Data Shows GT005 Well Tolerated in Patients With Geographic Atrophy MT
Myriad : Syncona Expands Investment In Quell Therapeutics By $35 Million MT
Myriad : Syncona's Expects COVID-19 to Not impact Valuations as Net Asset Value Declines in Q4 2020 MT
Myriad : Syncona's Autolus Prices $100 Million Public Offering in US MT
Myriad : Syncona Unit Freeline Therapeutics Makes Changes In Clinical Development Plan for Hemophilia B Trial MT
Myriad : Syncona's Achilles Therapeutics to Continue Clinical Trials on T Cell Therapies to Treat Solid Tumors MT
Myriad : Syncona's Achilles Therapeutic Mulls IPO in US MT
Myriad : Syncona Portfolio Company Autolus to Cut 20% Workforce in Q1 MT
Myriad : Syncona Launches New Gene Therapy Company MT
Myriad : Earnings Flash (SYNC.L) SYNCONA Posts H1 EPS GBX17.86 MT
Myriad Group AG(SWX:MYRN) dropped from Swiss Performance Index (Price Return) CI
Myriad Group AG Provides Earnings Guidance for the Year Ended December 31, 2017 CI
Myriad Group AG(SWX:MYRN) dropped from S&P Global BMI Index CI
Myriad Group AG Announces Board Appointments CI
Myriad Group AG Announces Earnings Results for the Half Year of 2017 CI
Myriad Group Announces Resignation of Mauro Saladini from Board of Directors CI
Myriad Group AG Launches New Service to Reduce SIM-Swap Fraud CI
Chart Myriad Group AG
More charts
Myriad Group AG is a Switzerland-based company. The Company provides mobile USSD technology, empowering enterprises to deliver new mobile services to enhance customer engagements and improve service delivery, regardless of device or connection. It products and services are integrated within mobile networks, exposing capabilities and core network assets to enterprises, offering unparalleled reach, security, and service.
More about the company
  1. Stock
  2. Equities
  3. Stock Myriad Group AG - Swiss Exchange
  4. News Myriad Group AG
  5. Myriad : Syncona Unit Freeline Therapeutics Makes Changes In Clinical Development Plan for Hemophilia B Trial